Esperite N.V.

Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.

  • Publicatie datum 19 mei 2015 - 07:24
  • Statutaire naam Esperite N.V.
  • Titel ESPERITE N.V. Trading Update. Q1 confirms strategy and forecasted growth with Genoma
  • Bericht The company is now building the future. CryoSave is on track and Genoma shows its ability to support the current published forecasts and ambitious next developments. Zutphen, The Netherlands - 19 May 2015 ESPERITE N.V. (Euronext: ESP, 'ESPERITE', or 'the Group') announces its trading update for the quarter ended 31 March 2015. ESPERITE has accomplished significant milestones set forth for Q1. Economic circumstances have improved over the past months and ESPERITE is confident that the incremental revenues forecasted for its multiproduct strategy will outgrow the market. ESPERITE's strategic development is fully on track.

Gerelateerde downloads

201505190000000005_ESP PR Q1 19.05.2015.pdf

Datum laatste update: 26 januari 2021

Informatie delen

Delen via: deel